Tag: heart failure

Sedentary Postmenopausal Women Have Higher HF Risk

The more time older women spent sitting or lying down, the more likely their risk of hospitalization for heart failure, based on data from more...

No Extra Cardiopulmonary Event Reduction With High-Dose Flu Vac

The high-dose influenza vaccine was not more effective than a standard-dose vaccine in lowering the risk for death or hospitalizations for cardiac or pulmonary events...

Restful Sleep Could Help Ward Off Heart Failure

The researchers gave each person a “healthy sleep score” of 0 to 5, based on the number of healthy habits they...

Rivaroxaban Rivals Warfarin in AF, Mitral Bioprosthesis

The direct oral anticoagulants (DOACs) took cardiology by storm a decade ago when trials showed they were at least as safe and effective as warfarin...

No Secondary Prevention Benefit With Omega-3s in Elderly

Omega-3 fatty acids on top of standard care did not reduce major cardiovascular events or death in elderly survivors of an acute myocardial infarction (MI)...

Empagliflozin Favorably Reshaped LVs in HFrEF Patients

Treatment with the SGLT2 inhibitor empagliflozin led to significant reductions in both left ventricular end systolic and diastolic volumes in two independent randomized studies of...

New ‘Myotropic’ Class Has Modest HFrEF Benefit

Omecamtiv mecarbil, a member of the novel myotropic drug class that improves cardiac performance, safely produced a significant but modest improvement in heart failure events...

New Reports Guide Return to Play in Athletes With COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Increasingly, clinicians are being called upon to advise athletes who have...

Data Contradict on Statin Effect in Diabetes With COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two observational studies have yielded opposite findings regarding the effect of...

Some HF Patients Discard LVAD After ‘Heart Recovery’ Protocol

Although structural and functional heart “recovery” sometimes follows implantation of a left ventricular assist device (LVAD) in patients with end-stage heart failure (HF), allowing pump...

Benefits of SGLT2 Inhibitors Seen Across Patient Subgroups

Two different SGLT2 inhibitors produced broadly consistent beneficial effects across a spectrum of patients in two recent pivotal trials: one that enrolled patients with heart...

Med Student’s Cardiac Crisis a COVID-Era Medical Mystery

Medical student Ramya Yeleti after her incredible recovery. Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Within minutes of...

Dapagliflozin Halves Hyperkalemia in Some HF Patients

For patients with heart failure with reduced ejection fraction (HFrEF), the addition of dapagliflozin (Farxiga) to a mineralocorticoid receptor antagonist (MRA) halved the incidence of...

Troponin, Echo a Prognostic Power Combo in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The prevalence of troponin-defined myocardial injury exceeded 60% among selected patients...

HFSA Experts Tout Immediate Quadruple Therapy for HFrEF Patients

Start most patients newly diagnosed with heart failure with reduced ejection fraction on the disorder’s four foundational drug regimens all at once, all on the...

Many Seniors With Heart Failure Take 10-plus Meds

By Cara Roberts Murez HealthDay Reporter TUESDAY, Oct. 13, 2020 (HealthDay News) — When older people hospitalized for heart failure are...

Vericiguat Benefits Even With High Adherence to HFrEF Meds

Vericiguat (Merck/Bayer), among the latest drugs to gain cred in heart failure (HF) with reduced ejection fraction (HFrEF), significantly benefits patients who are highly adherent...

Levosimendan Hints at Benefit in Unusual Form of Heart Failure

An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype...

Music’s Charms May Soothe Heart Failure’s Effects

Music listening and singing each showed early, promising evidence for producing cardiovascular benefits, part of a burgeoning area of research that is exploring and documenting...

Cell Therapy for Anthracycline Cardiomyopathy Safe, Feasible

In yet another trial of cell therapy for heart failure, this time in cancer survivors with anthracycline-induced cardiomyopathy (AIC), administration of allogeneic bone marrow-derived mesenchymal...

Ertugliflozin Benefit Falls Short of Other SGLT2 Inhibitors

Further analyses from the cardiovascular outcome trial of the sodium-glucose transporter 2 inhibitor ertugliflozin in patients with type 2 diabetes helped better define positive effects...

Resuming Sex After Heart Attack May Help Recovery

By E.J. Mundell HealthDay Reporter WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Many heart attack survivors worry that resuming sex too soon afterwards might...

Even Low-Dose Glucocorticoids Up Infection Risk in RA

Even low-dose glucocorticoids (GCs) are associated with a small but significant increased risk for infection among hospitalized patients with rheumatoid arthritis (RA), a study has...

‘Cautious’ DOAC Underdosing in AF May Push Mortality Higher

The risk for death goes up for patients with atrial fibrillation (AF) who are put on direct oral anticoagulants (DOAC) at dosages other than those...

European Sports Cardiology Guidelines Break New Ground

New guidelines on sports cardiology from the European Society of Cardiology break fresh ground by green-lighting participation in vigorous competitive sports by selected patients with...